Mastocytosis: Clinical Trials

137 trials for Mastocytosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

73 completed, 19 recruiting, 14 unknown, 13 terminated. 47 Phase 2, 16 Not applicable, 14 Phase 1, 14 Phase 3, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 247Completed 28, Terminated 6, Unknown 5, Active not recruiting 3, Recruiting 2, Withdrawn 2, Not yet recruiting 1
Not applicable16Completed 8, Terminated 3, Unknown 3, Withdrawn 2
Phase 114Completed 10, Terminated 2, Active not recruiting 1, Withdrawn 1
Phase 314Completed 8, Unknown 4, Recruiting 1, Terminated 1
Phase 42Completed 1, Recruiting 1
Early Phase 11Completed 1

Follow Mastocytosis: new trials by email Literature Review of Mastocytosis trials Research Report on Mastocytosis

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Depletion of CD45RA Positive Naive T Cells for the Prevention of Graft Versus Host Disease in Older Patients Undergoing Allogeneic Hematopoietic Cell Transplantation for Acute Leukemia or Myelodysplastic Syndrome
Allogeneic CD34+-enriched and CD45RA-depleted PBSCs, Biospecimen Collection, Bone Marrow Aspiration - Acute Biphenotypic Leukemia, Acute Leukemia
Phase 2Not yet recruitingFred Hutchinson Cancer Center522027-01-012026-09-14
Precision Medicine for Indolent Systemic Mastocytosis (PRISM)
Systemic Mastocytosis
Not yet recruitingMayo Clinic252026-09-092026-08-18
An Observational Study in Participants With Indolent Systemic Mastocytosis (ISM)
Indolent Systemic Mastocytosis
RecruitingBlueprint Medicines Corporation1502026-04-152026-09-04
A Non-Interventional Study in Participants With Indolent Systemic Mastocytosis (ISM) in Germany
Avapritinib - Indolent Systemic Mastocytosis
RecruitingBlueprint Medicines Corporation802025-12-092026-10-07
Screening Study for KIT D816V Mutated Mast Cell Disease in Select Populations
Screening - Clonal Mast Cell Disease, KIT D816V Mutation
RecruitingBlueprint Medicines Corporation7502025-10-172026-11-17
Peripheral Blood KIT-D816V Mutation in Adult Systemic Mastocytosis
Systemic Mastocytosis, KIT-D816V Mutation
RecruitingThe First Affiliated Hospital of Soochow University502025-05-192026-05-01
Analysis of the Role of IgE Proteoforms in Health and Disease
Blood sample collection - Anaphylaxis, Mastocytosis
RecruitingKU Leuven2002025-01-012026-01-09
Avapritinib Rollover Study
Avapritinib - Mastocytosis, Systemic
Phase 4RecruitingBlueprint Medicines Corporation602024-11-282026-11-12
Epidemiological Data on Mast Cell Pathologies in France
Mast Cell Disorder
RecruitingImagine Institute130002024-11-012026-04-22
Institutional Registry of Rare Diseases
Rare Diseases, Amyloidosis
RecruitingHospital Italiano de Buenos Aires3802024-07-012026-01-14
Mastocytosis Registry (of Zurich)
Mastocytosis, Hypertryptasemia
RecruitingUniversity of Zurich4002024-06-062024-06-26
Study of Cellular Heterogeneity in Patients With Mastocytosis
scRNAseq, two Skin biopsies, one Skin biopsies - Mastocytosis
Not applicableUnknownUniversity Hospital, Toulouse262024-06-012024-05-29
Quality of Life and Disease-related Symptoms in Individuals With Systemic Mastocytosis
No intervention - Mastocytosis, Systemic
Active not recruitingUppsala University4002024-03-252025-04-04
Mastocytosis From Pediatric Age to Adulthood: Local Registry of Cutaneous and Systemic Mastocytosis
Cutaneous Mastocytosis, Systemic Mastocytosis
RecruitingFondazione IRCCS Policlinico San Matteo di Pavia6002024-01-262025-08-26
Angioedema Biomarker Research Study
Venipuncture - Angioedema, Angioedemas, Hereditary
RecruitingFoundation For Rare Disease Research6002024-01-152026-08-24
Study of Elenestinib (BLU-263) in Advanced Systemic Mastocytosis (AdvSM) and and Other KIT Altered Hematologic Malignancies
BLU-263, Azacitidine - Advanced Systemic Mastocytosis
Phase 1TerminatedBlueprint Medicines Corporation92023-09-252025-04-10
A Registry for Patients With Systemic Mastocytosis in China
Systemic Mastocytoses
UnknownThe First Affiliated Hospital of Soochow University1502023-09-012023-10-10
New Italian Mastocytosis Registry
CLINICAL AND BIOLOGICAL DATA COLLECTION - Systemic Mastocytosis
RecruitingAssociazione Rete Italiana Mastocitosi15002023-05-152026-11-04
Evaluation of the DALY on a Cohort of Patients With Indolent Systemic Mastocytosis
Mastocytosis, Indolent Systemic
UnknownUniversity Hospital, Toulouse1602023-05-012023-07-12
A Study of MGD024 in Patients With Relapsed or Refractory Hematologic Malignancies
MGD024 - Leukemia, Acute Myeloid, Myelodysplastic Syndromes
Phase 1Active not recruitingMacroGenics1302022-07-132026-07-28

Showing 20 of 137. Sign in to see all of them.

Narrower conditions

Leukemia, Mast-Cell (60)  ·  Mastocytosis, Systemic (54)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (44)  ·  Leukemia, Biphenotypic, Acute (42)  ·  Leukemia, Myelomonocytic, Chronic (41)  ·  Leukemia, Hairy Cell (40)  ·  Leukemia, Myeloid, Acute (40)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (39)  ·  Leukemia, Large Granular Lymphocytic (37)  ·  Burkitt Lymphoma (35)  ·  Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative (34)  ·  Lymphoma, Large-Cell, Anaplastic (34)  ·  Lymphoma, T-Cell, Cutaneous (34)  ·  Mycosis Fungoides (34)

Broader conditions

Neoplasms by Histologic Type (137)  ·  Immune System Diseases (135)  ·  Mast Cell Activation Disorders (129)  ·  Neoplasms (127)  ·  Neoplasms, Connective and Soft Tissue (96)  ·  Neoplasms, Connective Tissue (95)  ·  Hemic and Lymphatic Diseases (79)  ·  Hematologic Diseases (73)  ·  Leukemia, Myeloid (68)  ·  Pathological Conditions, Signs and Symptoms (61)  ·  Neoplasms by Site (59)  ·  Disease Attributes (56)  ·  Pathologic Processes (56)  ·  Bone Marrow Diseases (53)

Interventions

Whole-Body Irradiation (7)  ·  fludarabine phosphate (7)  ·  Mycophenolic Acid (6)  ·  Cyclosporine (5)  ·  Peripheral Blood Stem Cell Transplantation (5)  ·  Therapeutics (5)  ·  avapritinib (5)  ·  Imatinib Mesylate (4)  ·  Psychiatric Rehabilitation (4)  ·  masitinib (4)  ·  midostaurin (4)  ·  Busulfan (3)  ·  Cyclophosphamide (3)  ·  Diphenhydramine (3)  ·  fludarabine (3)

Sponsors

Blueprint Medicines Corporation (11)  ·  National Institute of Allergy and Infectious Diseases (NIAID) (9)  ·  M.D. Anderson Cancer Center (8)  ·  University Hospital, Toulouse (7)  ·  Fred Hutchinson Cancer Center (6)  ·  Novartis Pharmaceuticals (5)  ·  AB Science (4)  ·  City of Hope Medical Center (4)  ·  Mayo Clinic (4)  ·  Wake Forest University Health Sciences (4)  ·  Assistance Publique - Hôpitaux de Paris (3)  ·  Cogent Biosciences, Inc. (3)  ·  Jason Robert Gotlib (3)  ·  National Cancer Institute (NCI) (3)  ·  UNC Lineberger Comprehensive Cancer Center (3)

Countries

United States (81)  ·  France (27)  ·  Germany (20)  ·  Italy (16)  ·  Spain (14)  ·  Netherlands (13)  ·  United Kingdom (13)  ·  Belgium (11)  ·  Canada (11)  ·  Norway (9)  ·  Poland (9)  ·  Australia (8)  ·  Switzerland (8)  ·  Austria (7)  ·  Denmark (4)

Top investigators

Jorge Cortes, MD (3)  ·  Olivier Lortholary, MD, PhD (3)  ·  Srdan Verstovsek, MD (3)  ·  Cristina Bulai Livideanu, MD (2)  ·  David Maloney (2)  ·  Elisabeth Paietta, PhD (2)  ·  Frank Siebenhaar, MD (2)  ·  Hirsh D Komarow, M.D. (2)  ·  Jason Gotlib (2)  ·  Kyoo H. Lee, MD (2)  ·  Luis Escribano, MD, PhD (2)  ·  Marcus Maurer, MD (2)  ·  Melody C Carter, M.D. (2)  ·  Rachael Easton, MD, PhD (2)

Results publications

PMID 35790816, PMID 21134978, PMID 27355533, PMID 32499241, PMID 35640224, PMID 15070706, PMID 16775235, PMID 17715389, PMID 18327587, PMID 18567837, PMID 18698002, PMID 19451433, PMID 20004787, PMID 21098399, PMID 21108325, PMID 21523798, PMID 22259028, PMID 22563089, PMID 22892471, PMID 23432617, PMID 23547655, PMID 24057647, PMID 24150753, PMID 24474568, PMID 25605272, PMID 26002753, PMID 26175532, PMID 26476479, PMID 26700120, PMID 26700123, PMID 28069279, PMID 28744009, PMID 29890238, PMID 30205939, PMID 31350306, PMID 32437738, PMID 32804590, PMID 33049057, PMID 34663404, PMID 34873345, PMID 34873347, PMID 35015828, PMID 35251038, PMID 35622074, PMID 36048877, PMID 38261392, PMID 38320129, PMID 38837707, PMID 39425617, PMID 39649724

NIH funding

P30CA015704 (5), P01CA018029 (3), 2016 (2), P30CA015083 (2), P30CA016086 (2), P30CA033572 (2), P30CA068485 (2), P30CA072720 (2), 2008 (1), 2015 (1), 2017 (1), 2018 (1), N01CM62202 (1), P01CA049605 (1), P01CA078902 (1)